In a blast from the past, COVID-19 vaccine developer Moderna (NASDAQ: MRNA) just made headlines in 2026. Shares jumped up ...

Sweeping U.S. policy changes under Health Secretary Robert F. Kennedy Jr. are having a ‌chilling effect ​on vaccine makers as ...

Dow Jones Top Company Headlines at 7 AM ET: Moderna, Merck Report Positive Results From Cancer-Vaccine Study | GSK ... Moderna and Merck's cancer vaccine reduced the risk of relapse or death for ...

The unprecedented changes have led to diminished vaccine usage, and created a drag that will likely dent revenues.

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

The University of Auckland is hosting the research as part of the Global COVID Vaccine Safety (GCoVS) Project. Scientists ...

Ten stocks soared higher on Wednesday, mirroring a broader market rally, as investors took path from a combination of earnings performance and bullish analyst outlooks, among others.

Sweeping policy changes under US Secretary of Health and Human Services Robert F. Kennedy Jr are having a chilling effect on vaccine makers as anti-vaccine rhetoric has turned into concrete changes in ...

U.S. stock futures rose on Thursday following Wednesday’s gains. Futures of major benchmark indices were higher. The indices settled higher on Wednesday, gaining more than 1% during the session after ...

The UK government is under increasing pressure on Monday to review its COVID-19 vaccine protocol in place for travellers from India, after its updated rules effective from next month failed to ...

A personalised mRNA vaccine developed by Moderna and Merck shows lasting benefits for patients with high-risk skin cancer.

New personalized skin cancer treatment shows success in preventing return of high-risk melanoma - Patients with severe ...